Transgene SA (EPA:TNG)

Transgene Revenue

Transgene had revenue of 2.99M EUR in the half year ending June 30, 2026, a decrease of -10.84%. This brings the company's revenue in the last twelve months to 5.62M, up 19.63% year-over-year. In the year 2025, Transgene had annual revenue of 7.21M with 13.49% growth.

• Revenue (ttm): 5.62M
• Revenue Growth: +19.63%
• P/S Ratio: 34.09
• Revenue / Employee: 38.79K
• Employees: 145
• Market Cap: 191.72M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.21M	857.00K	13.49%
Dec 31, 2024	6.35M	-1.55M	-19.58%
Dec 31, 2023	7.90M	-2.44M	-23.63%
Dec 31, 2022	10.34M	-7.07M	-40.60%
Dec 31, 2021	17.41M	7.50M	75.62%
Dec 31, 2020	9.92M	-3.82M	-27.80%
Dec 31, 2019	13.73M	-29.19M	-68.00%
Dec 31, 2018	42.92M	34.78M	427.00%
Dec 31, 2017	8.14M	-2.17M	-21.02%
Dec 31, 2016	10.31M	362.00K	3.64%
Dec 31, 2015	9.95M	-1.15M	-10.36%
Dec 31, 2014	11.10M	-4.64M	-29.46%
Dec 31, 2013	15.74M	2.67M	20.47%
Dec 31, 2012	13.06M	-1.39M	-9.59%
Dec 31, 2011	14.45M	334.00K	2.37%
Dec 31, 2010	14.11M	2.35M	19.95%
Dec 31, 2009	11.77M	-5.31M	-31.09%
Dec 31, 2008	17.07M	-10.97M	-39.11%
Dec 31, 2007	28.04M	22.49M	405.59%
Dec 31, 2006	5.55M	1.39M	33.57%
Dec 31, 2005	4.15M	-	-

Data Source: Fiscal.ai Last updated: Sep 25, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 3, 2026

Data Sources Report a data error